Synthesis and antifungal activity of 5,8-quinazolinedione derivatives modified at positions 6 and 7

Archives of Pharmacal Research

Volumn 27, Issue 10, 2004, Pages 990-996

  Ryu, Chung Kyu ^a   Shim, Ju Yeon ^a   Yi, You Jin ^a   Ik, Hwa Choi ^a   Mi, Jin Chae ^a   Han, Ja Young ^a   Jung, Ok Jai ^a  

^a Ewha Womans University   (South Korea)

Author keywords

5,8 Quinazolinediones; A. niger; Antifungal; Candida species; MIC

Indexed keywords

5,8 QUINAZOLINEDIONE; 5,8-QUINAZOLINEDIONE; ANTIFUNGAL AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; QUINAZOLINE DERIVATIVE;

ARTICLE; ASPERGILLUS NIGER; CANDIDA; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; FUNGUS; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; CANDIDA; CHROMATOGRAPHY, THIN LAYER; FUNGI; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; QUINAZOLINES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 16644398351     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02975419     Document Type: Article

References (14)

1. Giorgi-Renault, S., Renault, J., Gebel-Servolles, P., Baron, M., Paoletti, C., Cros, S., Bissery, M. C., Lavelle, F., and Atassi, G., Heterocyclic quinones 17. A new in vivo active antineoplastic drug. J. Med, Chem., 34, 38-46 (1991).
2. Jeschke, P., Linder, W., Mueller, N., and Dehne, H. W., Fungicides based on amino-substituted quinolinequinones. Ger. Offen., DE 4,208,874 (1993); Chem. Abstr., 118, 233893 (1993).
3. Mcginnis, M. R. and Rindali, M. G., Antifungal drug: In Lorian, V. (Eds.). Antibiotics in Laboratory Medicine (4th ed.). Williams and Wilkins, Baltimore, pp 176-211 (1996).
4. Melesani, G., Marcolin, F., and Rodighiero, G., Synthesis of 5,8-quinazolinedione. J. Med. Chem., 13, 161-162 (1970).
5. Middleton, R. W. and Parrick, J., Heterocyclic quinones: Patai, S., Rappoport, Z.(Eds), The Chemistry of The Quinonoid Compounds. John Wiley & Sons: London, vol 2, pp 1019-1066 (1988).
6. Park, H. J., Kim, Y.-S., Kim, J. S., Lee, H.-J., Lee, E.-J., Hwang, H. J., Suh, M.-E., Ryu, C.-K., and Lee, S. K., 6-Arylamino-7-chloro-quinazoline-5, 8-diones as novel cytotoxic and DNA toposiomerase inhibitory agents. Bioorg. Med. Chem. Lett., 14, 3385-3388 (2004).
7. Renault, J., Giorgi-Renault, S., Baron, M., Mailliet, P., Paoletti, C., Cros, S., Viosin, E., and Renault, J., Heterocyclic quinone 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8-quinazolinedione. J. Med. Chem., 26, 1715-1719 (1983).
8. Roberts, H., Choo, W. M., Smith, S. C., Marzuki, S., Linnane, A. W., Porter, T. H., and Folkers, K., The site of inhibition of mitochondrial electron transfer by coenzyme Q analogs. Arch. Biochem. Biophys., 191, 306-315 (1978).
9. Ryu, C.-K. and Kim, H. J., The synthesis of 6-(N-arylamino)-7-chloro-5,8- quinolinedione derivatives for evaluation of antifungal activities. Arch. Pharm. Res., 17, 139-144 (1994).
10. Ryu, C.-K., Shin, K.H., Seo, J. H., and Kim, H. J., 6-Arylamino-5,8- quinazolinediones as potent inhibitors of endothelium-dependent vasorelaxation. European J. Med. Chem., 37, 77-82 (2002a).
11. Ryu, C.-K., Sun, Y. J., Shim, J.Y., You, H. J., Choi, K.U., and Lee, H., Synthesis and antifungal activities of 6,7-bis-[S-(aryl)thio]-5,8- quinolinediones. Arch. Pharm. Res., 25, 784-789 (2002b).
12. Ryu, C.-K., Yi, Y.-J., Choi, I. H., Chae, M J., Han, J.-Y., Jung, O.-J., and Lee, C.-O., Synthesis and cytotoxic activity of 6-(substituted-phenyl)amino- 5,8-quinazolinediones. Med. Chem. Res., 13 in press (2004).
13. Shaikh, I. A., Johnson, F., and Grollman, A. P., Structure-activity relationship among simple bicyclic analogues. Rate dependent of DNA degradation on quinone reduction potential. J. Med. Chem., 29, 1329-1340 (1986).
14. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, T. W., Bokesch, H., Kenney, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).